Physicare Laboratories Profile
Key Indicators
- Authorised Capital ₹ 5.00 M
- Paid Up Capital ₹ 3.19 M
- Company Age 42 Year, 10 Months
- Last Filing with ROC 31 Mar 2019
- Open Charges ₹ 5.18 M
- Revenue Growth %
- Ebitda
- Net Worth -0.03%
- Total Assets %
About Physicare Laboratories
Physicare Laboratories Pvt Ltd (PLPL) is a Private Limited Indian Non-Government Company incorporated in India on 01 April 1982 and has a history of 42 years and ten months. Its registered office is in Mumbai, Maharashtra, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2019. It's a company limited by shares with an authorized capital of Rs 5.00 M and a paid-up capital of Rs 3.19 M.
The company currently has active open charges totaling ₹5.18 M.
Asha Turakhia, Prakash Turakhia, and Olive Pereira serve as directors at the Company.
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U24239MH1982PTC026824
- Company No.
026824
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
01 Apr 1982
- Date of AGM
30 Sep 2019
- Date of Balance Sheet
31 Mar 2019
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Who are the key members and board of directors at Physicare Laboratories?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Asha Turakhia  | Director | 01-Apr-1982 | Current |
| Prakash Turakhia | Director | 01-Apr-1982 | Current |
| Olive Pereira | Director | 01-Apr-1982 | Current |
Financial Performance of Physicare Laboratories.
Physicare Laboratories Pvt Ltd, for the financial year ended 2017, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth dipped by a decrease of 0.03%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth |
| ||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Physicare Laboratories?
In 2017, Physicare Laboratories had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹5.18 M
₹0
Charges Breakdown by Lending Institutions
- Dena Bank : 0.52 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 12 Dec 1998 | Dena Bank | ₹4.70 M | Open |
| 17 Jan 1994 | Dena Bank | ₹0.45 M | Open |
| 10 May 1983 | Dena Bank | ₹0.03 M | Open |
How Many Employees Work at Physicare Laboratories?
Unlock and access historical data on people associated with Physicare Laboratories, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Physicare Laboratories, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Physicare Laboratories's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.